Skip to content

Shares (Basic) at other companies

ALN
Alnylam PharmaceuticalsALNY
132.9M+2.5%
Septerna, Inc. logo
Septerna, Inc.SEPN
44.8M+1.9%
Regenxbio logo
RegenxbioRGNX
52.4M+2.1%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
91.3M+5.7%
Opko Health logo
Opko HealthOPK
758.9M+13.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
59.6M+9.8%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's shares (basic)?
Tectonic Therapeutics (TECX) reported shares (basic) of 18.8M in Q1 2026.
How has Tectonic Therapeutics's shares (basic) changed year-over-year?
Tectonic Therapeutics's shares (basic) increased by 9.4% year-over-year, from 17.2M to 18.8M.
What is the long-term trend for Tectonic Therapeutics's shares (basic)?
Over 3 years (2022 to 2025), Tectonic Therapeutics's shares (basic) has grown at a -25.3% compound annual growth rate (CAGR), from 174.9M to 72.9M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.